Literature DB >> 33994720

Recurrent Hepatic Encephalopathy Due to Surgically Created Shunt During Living Donor Liver Transplantation.

Narendra S Choudhary1, Sanjiv Saigal1, Neeraj Saraf1, Sanjay S Baijal2, Arvinder S Soin1.   

Abstract

Hepatic encephalopathy due to portosystemic shunts is a well-defined entity in patients with cirrhosis. Rarely, liver transplant recipients develop hepatic encephalopathy owing to persistence or surgically created portosystemic shunts. We present a case of post-transplant recurrent hepatic encephalopathy due to a surgically created portocaval shunt. The patient was managed by a covered metal stent placement in the inferior vena cava, thus causing functional closure of the shunt.
© 2020 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HE, hepatic encephalopathy; HPCS, hemiportocaval shunt; LDLT, living donor liver transplantation; PS, portosystemic shunt; SFSS, small-for-size syndrome; ammonia; hepatic encephalopathy; liver transplantation; shunt; stent

Year:  2020        PMID： 33994720      PMCID： PMC8103351          DOI： 10.1016/j.jceh.2020.08.004

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN： 0973-6883


  9 in total

1.  Hepatic encephalopathy after liver transplantation in a patient with a normally functioning graft: Treatment with embolization of portosystemic collaterals.

Authors:  J Ignacio Herrero; Jose Ignacio Bilbao; Maria Lourdes Diaz; Felix Alegre; Mercedes Inarrairaegui; Fernando Pardo; Jorge Quiroga
Journal:  Liver Transpl       Date:  2009-01       Impact factor: 5.799

Review 2.  Small-for-size syndrome in LT.

Authors:  Taizo Hibi; Yuko Kitagawa
Journal:  Clin Liver Dis (Hoboken)       Date:  2017-10-31

3.  Smoothing the path: reducing biliary complications, addressing small-for-size syndrome, and making other adaptations to decrease the risk for living donor liver transplant recipients.

Authors:  Arvinder S Soin
Journal:  Liver Transpl       Date:  2012-11       Impact factor: 5.799

4.  Postshunt encephalopathy in liver transplanted children with portal vein thrombosis.

Authors:  P Tissières; D Pariente; C Chardot; F Gauthier; D Devictor; D Debray
Journal:  Transplantation       Date:  2000-11-27       Impact factor: 4.939

5.  Is Portal Inflow Modulation Always Necessary for Successful Utilization of Small Volume Living Donor Liver Grafts?

Authors:  Arvinder Singh Soin; Sanjay Kumar Yadav; Sujeet Kumar Saha; Amit Rastogi; Prashant Bhangui; Thiagarajan Srinivasan; Neeraj Saraf; Narendra S Choudhary; Sanjeev Saigal; Vijay Vohra
Journal:  Liver Transpl       Date:  2019-10-01       Impact factor: 5.799

6.  Postshunt hepatic encephalopathy in liver transplant recipients.

Authors:  Marius M Braun; Nathan Bar-Nathan; Ezra Shaharabani; Sigal Aizner; Ran Tur-Kaspa; Alexander Belenky; Eitan Mor; Ziv Z Ben-Ari
Journal:  Transplantation       Date:  2009-03-15       Impact factor: 4.939

7.  Balloon-occluded retrograde transvenous obliteration in a patient with hyperammonemic encephalopathy after living donor liver transplantation.

Authors:  Satoshi Yokoyama; Mureo Kasahara; Akinari Fukuda; Shinji Uemoto; Shunsuke Nosaka
Journal:  Liver Transpl       Date:  2007-08       Impact factor: 5.799

8.  Hepatic encephalopathy in a liver transplant recipient with stable liver function.

Authors:  Juan Pablo Arab; Luis Meneses; Rosa M Pérez; Marco Arrese; Carlos Benítez
Journal:  Hepatology       Date:  2013-04       Impact factor: 17.425

9.  Results of Portosystemic Shunt Embolization in Selected Patients with Cirrhosis and Recurrent Hepatic Encephalopathy.

Authors:  Narendra S Choudhary; Sanjay Saran Baijal; Sanjiv Saigal; Amit Agarwal; Neeraj Saraf; Rohit Khandelwal; Vaibhav Jain; Anubhav Harish Khandelwal; Abhay Kapoor; Deepak Jain; Smurti R Misra; Rajesh Puri; Randhir Sud; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2017-04-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.